abinScience – Powering Breakthroughs in Life Science Research
About Us
As a strategic venture of AtaGenix (established 2011), abinScience was founded in 2023 to deliver premium life science reagents that accelerate discovery. We combine 14+ years of proven expertise with innovative approaches to provide researchers worldwide with reliable, high-performance catalog products.
Technology & Innovation
Leveraging AtaGenix's proven expertise, our catalog products are developed by using the following technologies:
✅ Advanced Protein Expression Systems – Optimized for high-yield production
✅ De Novo Antibody Discovery Platform – For novel target development
✅ Next-Generation antibody Engineering – Incorporating AI-assisted design
Our proprietary technologies are validated by leading research institutions, ensuring reproducible results across applications.
Comprehensive Product Solutions
Core Offerings:
▸ Protein Portfolio
• 10,000+ rigorously validated proteins
• Includes cytokines, enzymes, and recombinant proteins
▸ Antibody Solutions
• 30,000+ research-grade antibodies covering:
· Classic & monoclonal antibodies
· Phosphorylation-specific clones
· Nanobodies & single-domain antibodies
· Flow-optimized antibodies (minimal background)
· Specialized antibodies (DNA/RNA, PEG, etc.)
▸ Ready-to-Use Kits
• 1,000+ validated assay kits
▸ Custom Development Services
• Antibody engineering & optimization
• Protein expression & purification
• Molecular biology services
Research Applications
Our solutions support cutting-edge research in:
• Infectious Diseases – Emerging pathogens, antimicrobial resistance
• Neuroscience – Neurodegeneration mechanisms & therapeutic targets
• Immunology – Immune cell signaling, checkpoint regulation
• Oncology – Tumor microenvironment studies, immunotherapy development
Our Commitment
At abinScience, we bridge discovery and application through:
• Scientifically-validated reagents
• Technical expertise honed over 14+ years
• Custom solutions for challenging targets
